Patents by Inventor Charles G. Supino

Charles G. Supino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5735878
    Abstract: An implantable defibrillator derives a rectangular current waveform from a capacitor discharge by using a current limiter. This pulse-shaping method is equally applicable to single-path and multiple-path situations. A rectangular pulse delivers a maximum of energy for a given peak-field value with a particular electrode combination and pulse duration. Peak field is a measure of the tissue-damage potentiality of a particular discharge.
    Type: Grant
    Filed: December 22, 1995
    Date of Patent: April 7, 1998
    Assignee: Angeion Corporation
    Inventors: Mark W. Kroll, Theodore P. Adams, Charles G. Supino
  • Patent number: 5514160
    Abstract: An implantable defibrillator derives a rectangular current waveform from a capacitor discharge by using a current limiter. This pulse-shaping method is equally applicable to single-path and multiple-path situations. A rectangular pulse delivers a maximum of energy for a given peak-field value with a particular electrode combination and pulse duration. Peak field is a measure of the tissue-damage potentiality of a particular discharge.
    Type: Grant
    Filed: April 22, 1994
    Date of Patent: May 7, 1996
    Assignee: Angeion Corporation
    Inventors: Mark W. Kroll, Theodore P. Adams, Charles G. Supino
  • Patent number: 5447521
    Abstract: A defibrillator pulse generator for pectoral implant utilizing the metal case as an electrode and operative to supply unique patterns of monophasic, biphasic, or pairs of electrical pulses to the connected electrodes.
    Type: Grant
    Filed: October 12, 1994
    Date of Patent: September 5, 1995
    Assignee: Angeion Corporation
    Inventors: Kenneth M. Anderson, Theodore P. Adams, Charles G. Supino, Mark W. Kroll
  • Patent number: 5441518
    Abstract: An implantable multichamber cardioversion and defibrillation system is provided with multiple independently controllable and programmable switched electrode discharge pathways. This independently controlled switching arrangement provides for control over the polarity, phase, direction and timing of all cardioversion and defibrillation countershocks, and allows for the varying of subsequent countershocks after an initial countershock. The switching arrangement is, preferably, both programmable prior to implantation of the system and re-programmable after implantation of the system.
    Type: Grant
    Filed: July 22, 1993
    Date of Patent: August 15, 1995
    Assignee: Angeion Corporation
    Inventors: Theodore P. Adams, Charles G. Supino, Mark W. Kroll
  • Patent number: 5411526
    Abstract: The first embodiment of the present invention repositions the shunt thyristor used in the monophasic-waveform generator of the prior art so that it discharges the main capacitor through a series thyristor, thus increasing current through it briefly, rather than reducing current through it. The result of this arrangement is that the node between the series thyristor and the heart is pulled rapidly to a low voltage, causing the shunt switch to discharge the cardiac capacitance, as well as the main capacitance. The consequence is that discharging the cardiac capacitance requires a reversal of current in the heart, which enhances the heart-stimulating effect of the defibrillating waveform. The resulting true-voltage-pulse waveform has an efficacy approximating that of a biphasic waveform and is achieved with a circuit no more complex than that used to generate a monophasic waveform.
    Type: Grant
    Filed: March 24, 1992
    Date of Patent: May 2, 1995
    Assignee: Angeion Corporation
    Inventors: Mark W. Kroll, Charles G. Supino, Theodore P. Adams, Dennis A. Brumwell
  • Patent number: 5376103
    Abstract: A defibrillator pulse generator for pectoral implant utilizing the metal case as an electrode and operative to supply unique patterns of monophasic, biphasic, or pairs of electrical pulses to the connected electrodes.
    Type: Grant
    Filed: March 19, 1992
    Date of Patent: December 27, 1994
    Assignee: Angeion Corporation
    Inventors: Kenneth M. Anderson, Theodore P. Adams, Charles G. Supino, Mark W. Kroll
  • Patent number: 5372605
    Abstract: An improved dual battery power system uses two separate battery power sources for an implantable cardioverter defibrillator, each having optimized characteristics for monitoring functions and for output energy delivery functions, respectively. The monitoring functions are supplied electrical power by a first battery source, such as a conventional pacemaker power source in the form of a lithium iodide battery which is optimized for long life at very low current levels. The output energy delivery functions are supplied by a separate second battery source, such as a pair of lithium vanadium pentoxide batteries, which is optimized for high current drain capability and low self-discharge for long shelf life. The first battery source provides electrical power only to the monitoring functions of the implantable cardioverter defibrillator, and the second battery source provides all of the electrical power for the output energy delivery functions.
    Type: Grant
    Filed: August 16, 1993
    Date of Patent: December 13, 1994
    Assignee: Angeion Corporation
    Inventors: Theodore P. Adams, Dennis A. Brumwell, Joseph S. Perttu, Charles G. Supino
  • Patent number: 5312443
    Abstract: A major shortcoming in the prior art for detecting cardiac arrhythmias for the purpose of making an electrical intervention decision has been that each variable sensed was given in effect a "veto" over intervention on the basis of its own particular predetermined threshold value, and irrespective of the values of companion variables. The present invention overcomes this prior art problem by generating a function of relevant variables, and assigning a threshold value to the function. As a result, an individual variable can range widely for a positive intervention decision, depending upon the values of the companion variables. Thus, the intervention exploits features often described as those associated with fuzzy logic. The functions chosen for this purpose can be as one desires, with the choice depending upon the current state of advancing knowledge.
    Type: Grant
    Filed: February 20, 1992
    Date of Patent: May 17, 1994
    Assignee: Angeion Corporation
    Inventors: Theodore P. Adams, Mark W. Kroll, Charles G. Supino
  • Patent number: 5306291
    Abstract: Epicardial-patch electrodes for defibrillation are efficient in deliverying electrical energy accurately to the necessary tissue and in minimizing electrical losses, but they are risky and costly because their implantation requires major surgery. Intravenous implantation of endocardial-coil electrodes, such as right-ventricular-apex (RVA) and superior-vena-cava (SVC) electrodes, by means of cardiac catheters, on the other hand, involves simpler procedures. Also, implantation of a subcutaneous-patch (SUB) electrode or of a pulse-generator housing (CAN, subject to co-pending application) electrode requires comparatively minor surgery. Using these last four electrodes, however, involves accepting electrical losses in intervening tissue, relatively inefficient current directions in some cases, and unfavorable energy distributions among paralleled paths.
    Type: Grant
    Filed: February 26, 1992
    Date of Patent: April 26, 1994
    Assignee: Angeion Corporation
    Inventors: Mark W. Kroll, Theodore P. Adams, Charles G. Supino
  • Patent number: RE38777
    Abstract: An improved dual battery power system uses two separate battery power sources for an implantable cardioverter defibrillator, each having optimized characteristics for monitoring functions and for output energy delivery functions, respectively. The monitoring functions are supplied electrical power by a first battery source, such as a conventional pacemaker power source in the form of a lithium iodide battery which is optimized for long life at very low current levels. The output energy delivery functions are supplied by a separate second battery source, such as a pair of lithium vanadium pentoxide batteries, which is optimized for high current drain capability and low self-discharge for long shelf life. The first battery source provides electrical power only to the monitoring functions of the implantable cardioverter defibrillator, and the second battery source provides all of the electrical power for the output energy delivery functions.
    Type: Grant
    Filed: December 13, 1996
    Date of Patent: August 16, 2005
    Assignee: Angeion Corp.
    Inventors: Theodore P. Adams, Dennis A. Brumwell, Joseph S. Perttu, Charles G. Supino